Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors

BACKGROUND: Adoptive T-cell transfer has become an attractive therapeutic approach for hematological malignancies but shows poor activity against large and heterogeneous solid tumors. Interleukin-12 (IL-12) exhibits potent antitumor efficacy against solid tumors, but its clinical application has bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jiemiao, Yang, Qing, Zhang, Wendong, Du, Hongwei, Chen, Yuhui, Zhao, Qingnan, Dao, Long, Xia, Xueqing, Natalie Wall, Fowlkes, Zhang, Zhongting, Mahadeo, Kris, Gorlick, Richard, Kopetz, S, Dotti, Gianpietro, Li, Shulin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762133/
https://www.ncbi.nlm.nih.gov/pubmed/35027427
http://dx.doi.org/10.1136/jitc-2021-003633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762133/
https://www.ncbi.nlm.nih.gov/pubmed/35027427
http://dx.doi.org/10.1136/jitc-2021-003633

Ejemplares similares